Attention deficit hyperactivity disorder [NEW TOPIC PAGE]

Main|Search|PHGKB




Last Posted: Apr 02, 2019

---

• Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations.
  Antshel Kevin M et al. Current psychiatry reports 2019 Mar 21(5) 34
• Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy.
  Brown Jacob T et al. Clinical pharmacology and therapeutics 2019 Feb
• Sibling Recurrence Risk and Cross-aggregation of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.
  Miller Meghan et al. JAMA pediatrics 2018 Dec
• A vast study seeks to understand the genetic underpinnings of ADHD
  The Economist, November 2018
• Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
  D Demontis et al, Nat Genetics, November 26, 2018
• Do borderline personality disorder and attention-deficit/hyperactivity disorder co-aggregate in families? A population-based study of 2 million Swedes.
  Kuja-Halkola Ralf et al. Molecular psychiatry 2018 Oct
• Familial association of attention-deficit hyperactivity disorder with autoimmune diseases in the population of Sweden.
  Li Xinjun et al. Psychiatric genetics 2018 Nov
• Twenty years of research on attention-deficit/hyperactivity disorder (ADHD): looking back, looking forward.
  Cortese Samuele et al. Evidence-based mental health 2018 Nov 21(4) 173-176
• Risk and coaggregation of major psychiatric disorders among first-degree relatives of patients with bipolar disorder: a nationwide population-based study.
  Chen Mu-Hong et al. Psychological medicine 2018 Nov 1-8
• Associations between polygenic risk scores for four psychiatric illnesses and brain structure using multivariate pattern recognition.
  Ranlund Siri et al. NeuroImage. Clinical 2018 Oct 201026-1036

more